Aldeyra Therapeutics Inc logo

Aldeyra Therapeutics Inc

NAS:ALDX (USA)  
$ 9.03 -0.03 (-0.33%) 11:10 PM EST
P/E:
At Loss
P/B:
3.50
Market Cap:
$ 528.80M
Enterprise V:
$ 370.58M
Volume:
1.51M
Avg Vol (2M):
538.10K
Also Trade In:
Volume:
1.51M
Market Cap $:
528.80M
PE Ratio:
At Loss
Avg Vol (2M):
538.10K
Enterprise Value $:
370.58M
PB Ratio:
3.50

Business Description

Description
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
Name Current Vs Industry Vs History
Cash-To-Debt 10.84
Equity-to-Asset 0.83
Debt-to-Equity 0.11
Debt-to-EBITDA -0.27
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 80.77
9-Day RSI 73.32
14-Day RSI 69.41
6-1 Month Momentum % 31.62
12-1 Month Momentum % 48.55

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 11.78
Quick Ratio 11.78
Cash Ratio 11.35

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -26.9

Financials (Next Earnings Date:2023-05-05 Est.)

ALDX's 30-Y Financials

How Aldeyra Therapeutics Inc (ALDX) Makes Its Money

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ALDX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Executives

Details

Valuation chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.06
Beta 0.88
Volatility % 75.9
14-Day RSI 69.41
14-Day ATR ($) 0.500105
20-Day SMA ($) 7.6095
12-1 Month Momentum % 48.55
52-Week Range ($) 2.355 - 9.2
Shares Outstanding (Mil) 58.56

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Aldeyra Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Aldeyra Therapeutics Inc Stock Events

Event Date Price($)
No Event Data

Aldeyra Therapeutics Inc Frequently Asked Questions

What is Aldeyra Therapeutics Inc(ALDX)'s stock price today?
The current price of ALDX is $9.03. The 52 week high of ALDX is $9.20 and 52 week low is $2.36.
When is next earnings date of Aldeyra Therapeutics Inc(ALDX)?
The next earnings date of Aldeyra Therapeutics Inc(ALDX) is 2023-05-05 Est..
Does Aldeyra Therapeutics Inc(ALDX) pay dividends? If so, how much?
Aldeyra Therapeutics Inc(ALDX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1